Результаты поиска - Andrew J. Armstrong

Отмена результатов
  1. 1
    Evolving standards in the treatment of docetaxel-refractory castration-resistant prostate cancer

    Evolving standards in the treatment of docetaxel-refractory castration-resistant prostate cancer по Emmanuel S. Antonarakis, Andrew J. Armstrong

    Опубликовано 2011
    Полный текст
    Revisão
    Добавить в Избранное
    Сохранить в:
  2. 2
    Targeting the PI3K/Akt/mTOR pathway in castration-resistant prostate cancer

    Targeting the PI3K/Akt/mTOR pathway in castration-resistant prostate cancer по Rhonda L. Bitting, Andrew J. Armstrong

    Опубликовано 2013
    Полный текст
    Revisão
    Добавить в Избранное
    Сохранить в:
  3. 3
    Reply to R. Sun et al

    Reply to R. Sun et al по Andrew J. Armstrong, Brad Rosbrook, Shunsuke Yamada

    Опубликовано 2022
    Полный текст Полный текст
    Carta
    Добавить в Избранное
    Сохранить в:
  4. 4
    Serum Lactate Dehydrogenase Predicts for Overall Survival Benefit in Patients With Metastatic Renal Cell Carcinoma Treated With Inhibition of Mammalian Target of Rapamycin

    Serum Lactate Dehydrogenase Predicts for Overall Survival Benefit in Patients With Metastatic Renal Cell Carcinoma Treated With Inhibition of Mammalian Target of Rapamycin по Andrew J. Armstrong, Daniel J. George, Susan Halabi

    Опубликовано 2012
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  5. 5
    Radium-223 chloride: a potential new treatment for castration-resistant prostate cancer patients with metastatic bone disease

    Radium-223 chloride: a potential new treatment for castration-resistant prostate cancer patients with metastatic bone disease по Michael R. Harrison, Daniel J. George, Wong, Andrew J. Armstrong

    Опубликовано 2013
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  6. 6
    Androgen receptor variant-driven prostate cancer: clinical implications and therapeutic targeting

    Androgen receptor variant-driven prostate cancer: clinical implications and therapeutic targeting по Emmanuel S. Antonarakis, Andrew J. Armstrong, Scott M. Dehm, Jun Luo

    Опубликовано 2016
    Полный текст
    Revisão
    Добавить в Избранное
    Сохранить в:
  7. 7
    Androgen receptor variant-driven prostate cancer II: advances in laboratory investigations

    Androgen receptor variant-driven prostate cancer II: advances in laboratory investigations по Changxue Lu, Landon C. Brown, Emmanuel S. Antonarakis, Andrew J. Armstrong, Jun Luo

    Опубликовано 2020
    Полный текст
    Revisão
    Добавить в Избранное
    Сохранить в:
  8. 8
    Biologic and clinical significance of androgen receptor variants in castration resistant prostate cancer

    Biologic and clinical significance of androgen receptor variants in castration resistant prostate cancer по Kathryn E. Ware, Mariano A. Garcia‐Blanco, Andrew J. Armstrong, Scott M. Dehm

    Опубликовано 2014
    Полный текст Полный текст
    Revisão
    Добавить в Избранное
    Сохранить в:
  9. 9
    The role of epithelial plasticity in prostate cancer dissemination and treatment resistance

    The role of epithelial plasticity in prostate cancer dissemination and treatment resistance по Rhonda L. Bitting, Daneen Schaeffer, Jason A. Somarelli, Mariano A. Garcia‐Blanco, Andrew J. Armstrong

    Опубликовано 2014
    Полный текст
    Revisão
    Добавить в Избранное
    Сохранить в:
  10. 10
    Clinical activity of abiraterone acetate in patients with metastatic castration-resistant prostate cancer progressing after enzalutamide

    Clinical activity of abiraterone acetate in patients with metastatic castration-resistant prostate cancer progressing after enzalutamide по Krista Noonan, Scott North, Rhonda L. Bitting, Andrew J. Armstrong, Susan Ellard, K.N. Chi

    Опубликовано 2013
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  11. 11
    Prediction of Survival following First-Line Chemotherapy in Men with Castration-Resistant Metastatic Prostate Cancer

    Prediction of Survival following First-Line Chemotherapy in Men with Castration-Resistant Metastatic Prostate Cancer по Andrew J. Armstrong, Elizabeth Garrett‐Mayer, Ronald de Wit, Ian F. Tannock, Mario A. Eisenberger

    Опубликовано 2009
    Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  12. 12
    Biomarkers of immunotherapy in urothelial and renal cell carcinoma: PD-L1, tumor mutational burden, and beyond

    Biomarkers of immunotherapy in urothelial and renal cell carcinoma: PD-L1, tumor mutational burden, and beyond по Jason Zhu, Andrew J. Armstrong, Terence W. Friedlander, Won Kim, Sumanta K. Pal, Daniel J. George, Tian Zhang

    Опубликовано 2018
    Полный текст Полный текст
    Revisão
    Добавить в Избранное
    Сохранить в:
  13. 13
    Navigating therapeutic sequencing in the metastatic castration-resistant prostate cancer patient journey

    Navigating therapeutic sequencing in the metastatic castration-resistant prostate cancer patient journey по Hannah D. McManus, Tanya B. Dorff, Alicia K. Morgans, Oliver Sartor, Neal D. Shore, Andrew J. Armstrong

    Опубликовано 2024
    Полный текст
    Revisão
    Добавить в Избранное
    Сохранить в:
  14. 14
    A Contemporary Prognostic Nomogram for Men with Hormone-Refractory Metastatic Prostate Cancer: A TAX327 Study Analysis

    A Contemporary Prognostic Nomogram for Men with Hormone-Refractory Metastatic Prostate Cancer: A TAX327 Study Analysis по Andrew J. Armstrong, Elizabeth Garrett‐Mayer, Yi-Chun Ou Yang, Ronald de Wit, Ian F. Tannock, Mario A. Eisenberger

    Опубликовано 2007
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  15. 15
    Molecular determinants for enzalutamide-induced transcription in prostate cancer

    Molecular determinants for enzalutamide-induced transcription in prostate cancer по Fuwen Yuan, William Hankey, Dayong Wu, Hongyan Wang, Jason A. Somarelli, Andrew J. Armstrong, Jiaoti Huang, Zhong Chen, Qianben Wang

    Опубликовано 2019
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  16. 16
    New and Emerging Therapies for Bone Metastases in Genitourinary Cancers

    New and Emerging Therapies for Bone Metastases in Genitourinary Cancers по Philip J. Saylor, Andrew J. Armstrong, Karim Fizazi, Stephen J. Freedland, Fred Saad, Matthew R. Smith, Bertrand Tombal, Kenneth J. Pienta

    Опубликовано 2012
    Полный текст
    Revisão
    Добавить в Избранное
    Сохранить в:
  17. 17
    Biomarkers in the Management and Treatment of Men with Metastatic Castration-Resistant Prostate Cancer

    Biomarkers in the Management and Treatment of Men with Metastatic Castration-Resistant Prostate Cancer по Andrew J. Armstrong, Mario A. Eisenberger, Susan Halabi, Stéphane Oudard, David M. Nanus, Daniel P. Petrylak, Oliver Sartor, Howard I. Scher

    Опубликовано 2011
    Полный текст
    Revisão
    Добавить в Избранное
    Сохранить в:
  18. 18
    Prostate-Specific Antigen Changes As Surrogate for Overall Survival in Men With Metastatic Castration-Resistant Prostate Cancer Treated With Second-Line Chemotherapy

    Prostate-Specific Antigen Changes As Surrogate for Overall Survival in Men With Metastatic Castration-Resistant Prostate Cancer Treated With Second-Line Chemotherapy по Susan Halabi, Andrew J. Armstrong, Oliver Sartor, Johann S. de Bono, Ellen B. Kaplan, Chen‐Yen Lin, Nicole Solomon, Eric J. Small

    Опубликовано 2013
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  19. 19
    Immunotherapy Is Changing First-Line Treatment of Metastatic Renal-Cell Carcinoma

    Immunotherapy Is Changing First-Line Treatment of Metastatic Renal-Cell Carcinoma по Matthew Labriola, Kristen A. Batich, Jason Zhu, Megan McNamara, Michael R. Harrison, Andrew J. Armstrong, Daniel J. George, Tian Zhang

    Опубликовано 2019
    Полный текст
    Revisão
    Добавить в Избранное
    Сохранить в:
  20. 20
    Novel therapies are changing treatment paradigms in metastatic prostate cancer

    Novel therapies are changing treatment paradigms in metastatic prostate cancer по Eric R. Powers, Georgia Sofia Karachaliou, Chester Kao, Michael R. Harrison, Christopher Hoimes, Daniel J. George, Andrew J. Armstrong, Tian Zhang

    Опубликовано 2020
    Полный текст Полный текст
    Revisão
    Добавить в Избранное
    Сохранить в:

Инструменты поиска: